Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Hongbo Lu currently holds 18,500 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hongbo Lu has been a net buyer of TPTX stock. They have purchased $27.8M and sold $228.3K worth of shares.
Hongbo Lu's most recent insider trade was on Jun 15, 2026, when they sold 18,500 shares at $0.00 per share.
Hongbo Lu serves as Executive at Turning Point Therapeutics, Inc. (TPTX). They have executed 22 insider transactions totaling $28.0M over their tenure at the company.
Hongbo Lu holds the position of Executive at Turning Point Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Hongbo Lu has shown a buying trading pattern, with $27.8M in total purchases and $228.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Hongbo Lu was on Dec 23, 2022, when they purchased $5.5M worth of TERN shares. This transaction involved 758,620 shares at $7.25 per share.
Hongbo Lu currently owns 18,500 shares of Turning Point Therapeutics, Inc. (TPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Hongbo Lu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Hongbo Lu has 22 Form 4 filings on record as an insider at Turning Point Therapeutics, Inc..
Set alerts for Hongbo Lu and 40,000+ other insiders.